🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are excited to share more about our program and what the Temple/Belton area has to offer this afternoon at 4p with TCEP MSC. #meettheprogram #emresidents #EMBound #medstudenttwitter emresidents

Pathophysiology in Hepatorenal Syndrome. #Terlipressin FDA approval

Great talk on Cardiorenal Syndrome by Chidozie Odigwe Renal everything.

In patients with CKD & type 2 diabetes, treatment w/ finerenone resulted in risks of CKD progression & CV events (vs placebo) #NephJC #Nephpearls #VisualAbstract by Michelle Lim nejm.org/doi/full/10.10…

FIDELIO-DKD Hypothesis: MR antagonism with finerenone slows CKD progression & reduces CV morbidity/ mortality with advanced CKD and Type 2 Diabetes #NephJC #Nephpearls

New exciting drugs in the Kidney 🌎 Finerenone

Excellent review be Dr.Moran on everything #COVID from @ackdonline BSWH Temple Nephrology

#WorldKidneyDay #850 million people living with kidney disease Join us Peloton tonight.

Excellent Journal club by Dr. Maghoub Mohammed #Flozinate BSWH Temple Nephrology

Excellent review by Dr. Tania Jesmine CKD-T Role of Toclizumab even in ABMR

BSWHTemple_Neph

#KidneyWk 2022 is coming! Join Nim Goraya MD FASN MD, FASN from BSWH Temple Nephrology, and other American Society of Nephrology kidney health professionals spotlighting their #United4KidneyHealth priority. Find out which priority resonates with Dr. Goraya most and why here:

#KidneyWk kicks off tomorrow! We can't wait to share stories from Glenda V. Roberts 😷, Samira Farouk, MD, MSCR, Jason Cobb, and Nim Goraya MD FASN during this year's plenary sessions to highlight opportunities in #kidney care. Join American Society of Nephrology's #United4KidneyHealth at 4KidneyHealth.org. A sneak peak⬇️

#AHA22 LBCTs one liners: 1. TRANSFORM-HF: Torsemide was not superior to furosemide in improving survival among patients treated for decompensated HF. 2. DCP: No differences in cardiovascular outcomes between chlorthalidone and HCTZ among elderly veterans with HTN.

Journal Club

Flozinate #EMPA Kidney Enthralled audience.

Excellent POCUS talk.

Nephrons at work. Renal physiology “ Burton Rose” followed by GN -IgA talk.

Theoretical distribution of intravenous fluids on infusion

#NKFClinicals BSWH Temple Nephrology Baylor Scott & White Temple IM Dept and Residency Awesome representation